Enzymes play a key role for hundreds of industrial purposes. The problem is that discovering the right enzyme with desired performance is like finding a needle in a haystack. Currently, there are two options: wait for evolution to take place or engineer it in the lab, costing millions of dollars and years of work with no guarantee of success. Allozymes unlocks enzyme potential using microfluidics, building the largest enzyme data set, and achieving 10X faster and cheaper development with 200X higher chance of success. Their ready to commercialize technology addresses a US$600B market with a pipeline of projects worth millions and products worth billions.
Dr Peyman Salehian
Entrepreneur-scientist, managed international team as Head of Business Development
Dr Akbar Vahidi
PhD in enzyme technology, delivered industrial projects to big pharma, food and biofuel companies